Bio-Path Holdings (BPTH) Misses Q4 EPS by 144c

Bio-Path Holdings (NASDAQ: BPTH) reported Q4 EPS of ($1.91), $1.44 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions